Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide

https://www.globenewswire.com/news-release/2024/05/23/2887601/0/en/Zealand-Pharma-announces-topline-results-from-the-mechanistic-investigator-led-DREAM-trial-with-low-doses-of-GLP-1-GLP-2-receptor-dual-agonist-dapiglutide.html

company announcement